High Growth Tech Stocks To Watch In The UK This October 2024
In This Article:
The UK market has recently faced challenges, with the FTSE 100 closing lower due to weak trade data from China and broader global economic concerns. In this environment, identifying high-growth tech stocks becomes crucial as investors seek opportunities that can thrive despite broader market volatility.
Top 10 High Growth Tech Companies In The United Kingdom
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| STV Group | 13.15% | 46.78% | ★★★★★☆ |
| Gaming Realms | 11.57% | 22.07% | ★★★★★☆ |
| YouGov | 14.29% | 29.79% | ★★★★★☆ |
| Altitude Group | 23.46% | 27.56% | ★★★★★☆ |
| Facilities by ADF | 52.00% | 144.70% | ★★★★★☆ |
| Redcentric | 4.89% | 63.79% | ★★★★★☆ |
| Windar Photonics | 63.60% | 126.92% | ★★★★★☆ |
| Beeks Financial Cloud Group | 24.63% | 57.95% | ★★★★★☆ |
| Oxford Biomedica | 20.98% | 106.13% | ★★★★★☆ |
| Vinanz | 113.60% | 125.86% | ★★★★★☆ |
Click here to see the full list of 47 stocks from our UK High Growth Tech and AI Stocks screener.
Let's review some notable picks from our screened stocks.
Genus
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Genus plc is an animal genetics company with operations across North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia and has a market cap of ￡1.32 billion.
Operations: Genus plc generates revenue primarily through its Genus ABS and Genus PIC segments, contributing ￡314.9 million and ￡352.5 million respectively. The company operates globally, including regions such as North America, Latin America, the UK, Europe, the Middle East, Russia, Africa, and Asia.
Despite a challenging year with earnings declining by 76.3%, Genus plc maintains a robust forecast with expected earnings growth at an impressive 39.4% annually, outpacing the UK market prediction of 14.3%. This resilience is underscored by their commitment to R&D, crucial for staying competitive in biotech innovation. However, revenue growth projections remain modest at 4.1% annually, slightly above the UK market's 3.8%. The company also upheld its dividend payout at 21.7 pence per share, demonstrating confidence in its financial stability and commitment to shareholder returns amidst fluctuating profits and a significant one-off loss of ￡47.4 million last fiscal year.
-
Take a closer look at Genus' potential here in our health report.
-
Explore historical data to track Genus' performance over time in our Past section.
NCC Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: NCC Group plc operates in the cyber and software resilience sectors across the United Kingdom, Asia-Pacific, North America, and Europe with a market cap of ￡542.72 million.
Operations: NCC Group plc's primary revenue streams come from Cyber Security (￡258.50 million) and Escode (￡65.90 million). The company operates in various regions, including the United Kingdom, Asia-Pacific, North America, and Europe.